AU2008204486C1 - Dbait and its standalone uses thereof - Google Patents

Dbait and its standalone uses thereof Download PDF

Info

Publication number
AU2008204486C1
AU2008204486C1 AU2008204486A AU2008204486A AU2008204486C1 AU 2008204486 C1 AU2008204486 C1 AU 2008204486C1 AU 2008204486 A AU2008204486 A AU 2008204486A AU 2008204486 A AU2008204486 A AU 2008204486A AU 2008204486 C1 AU2008204486 C1 AU 2008204486C1
Authority
AU
Australia
Prior art keywords
seq
use according
dna
molecule
dbait32hc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008204486A
Other languages
English (en)
Other versions
AU2008204486A1 (en
AU2008204486B2 (en
Inventor
Marie Dutreix
Jian-Sheng Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Museum National dHistoire Naturelle
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Museum National dHistoire Naturelle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Institut Curie, Museum National dHistoire Naturelle filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2008204486A1 publication Critical patent/AU2008204486A1/en
Assigned to MUSEUM NATIONAL D'HISTOIRE NATURELLE, INSTITUT CURIE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCH MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE reassignment MUSEUM NATIONAL D'HISTOIRE NATURELLE Amend patent request/document other than specification (104) Assignors: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT CURIE
Application granted granted Critical
Publication of AU2008204486B2 publication Critical patent/AU2008204486B2/en
Publication of AU2008204486C1 publication Critical patent/AU2008204486C1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/13Decoys
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/312Phosphonates
    • C12N2310/3125Methylphosphonates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/53Physical structure partially self-complementary or closed

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2008204486A 2007-01-12 2008-01-11 Dbait and its standalone uses thereof Ceased AU2008204486C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07300728.8 2007-01-12
EP07300728A EP1944369A1 (en) 2007-01-12 2007-01-12 Dbait and its standalone uses thereof
PCT/EP2008/050265 WO2008084087A2 (en) 2007-01-12 2008-01-11 Dbait and its standalone uses thereof

Publications (3)

Publication Number Publication Date
AU2008204486A1 AU2008204486A1 (en) 2008-07-17
AU2008204486B2 AU2008204486B2 (en) 2012-11-29
AU2008204486C1 true AU2008204486C1 (en) 2013-05-16

Family

ID=38515555

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008204486A Ceased AU2008204486C1 (en) 2007-01-12 2008-01-11 Dbait and its standalone uses thereof

Country Status (8)

Country Link
US (1) US8093366B2 (enExample)
EP (2) EP1944369A1 (enExample)
JP (1) JP5462632B2 (enExample)
CN (1) CN101622351B (enExample)
AU (1) AU2008204486C1 (enExample)
CA (1) CA2673972C (enExample)
EA (1) EA016053B1 (enExample)
WO (1) WO2008084087A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3135301T3 (pl) * 2010-06-22 2018-11-30 Onxeo Zoptymalizowany system dostarczania in vivo z czynnikami andosomolitycznymi koniugatów kwasów nukleinowych
AU2015202211B2 (en) * 2010-06-22 2016-09-01 Centre National De La Recherche Scientifique Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
EP2527440A1 (en) * 2011-05-27 2012-11-28 Institut Curie Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
JP6457696B2 (ja) * 2015-07-23 2019-01-23 アンスティテュ・キュリInstitut Curie 癌を処置するためのDbait分子とPARPインヒビターとの組合せの使用
EP3423068A1 (en) * 2016-03-01 2019-01-09 Onxeo Treatment of cancer by systemic administration of dbait molecules
WO2017186882A1 (en) * 2016-04-29 2017-11-02 Onxeo A method of predicting a response to an anti-tumor treatment by means of signal interfering dna molecules
WO2018162439A1 (en) 2017-03-08 2018-09-13 Onxeo New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule
EP3638252A4 (en) * 2017-06-12 2021-03-10 University of Miami Sting-dependent activators for treatment of disease
CN107793468A (zh) * 2017-06-26 2018-03-13 上海悦良生物科技有限公司 一种检测dna损伤的方法
EP3461488A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dbait molecule and a hdac inhibitor for treating cancer
WO2019175132A1 (en) * 2018-03-13 2019-09-19 Onxeo A dbait molecule against acquired resistance in the treatment of cancer
CN109321585B (zh) * 2018-09-30 2021-08-06 山东大学 一种利用t4脱氧核糖核酸连接酶提高原核微生物诱变育种效率的方法
CN113166762B (zh) 2018-12-21 2025-01-14 瓦莱里奥治疗公司 新的偶联核酸分子及其用途
AU2020242287A1 (en) 2019-03-21 2021-09-02 INSERM (Institut National de la Santé et de la Recherche Médicale) A Dbait molecule in combination with kinase inhibitor for the treatment of cancer
AU2020405068A1 (en) 2019-12-18 2022-07-07 Stinginn Llc Substituted 1,2, 4-triazoles and methods of use
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
WO2021178295A1 (en) * 2020-03-03 2021-09-10 University Of Washington Synthetic agonists of dna-pk and their use
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
TW202210633A (zh) 2020-06-05 2022-03-16 法商昂席歐公司 用於治療癌症之dbait分子與kras抑制劑的組合
AR122644A1 (es) 2020-06-19 2022-09-28 Onxeo Nuevas moléculas de ácido nucleico conjugado y sus usos
IL313439A (en) 2021-12-16 2024-08-01 Valerio Therapeutics New conjugated nucleic acid molecules and their uses
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005040378A1 (en) * 2003-10-24 2005-05-06 Institut Curie Nucleic acids useful for triggering tumor cell lethality

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005247807A (ja) * 2004-03-08 2005-09-15 Japan Science & Technology Agency Nsaidを利用した癌治療用組成物
US20060276423A1 (en) * 2005-04-18 2006-12-07 Rachel Altura Survivin-directed RNA interference-compositions and methods

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005040378A1 (en) * 2003-10-24 2005-05-06 Institut Curie Nucleic acids useful for triggering tumor cell lethality

Also Published As

Publication number Publication date
EA200900989A1 (ru) 2009-12-30
JP2010515707A (ja) 2010-05-13
JP5462632B2 (ja) 2014-04-02
WO2008084087A2 (en) 2008-07-17
EA016053B1 (ru) 2012-01-30
EP1944369A1 (en) 2008-07-16
AU2008204486A1 (en) 2008-07-17
CA2673972A1 (en) 2008-07-17
CN101622351B (zh) 2014-05-14
EP2102343B1 (en) 2015-07-08
AU2008204486B2 (en) 2012-11-29
CN101622351A (zh) 2010-01-06
US8093366B2 (en) 2012-01-10
CA2673972C (en) 2016-03-22
EP2102343A2 (en) 2009-09-23
EP1944369A9 (en) 2008-10-15
WO2008084087A3 (en) 2009-01-08
US20100022622A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
AU2008204486C1 (en) Dbait and its standalone uses thereof
EP2064327B1 (en) Dbait and uses thereof
AU2004284228B2 (en) Nucleic acids useful for triggering tumor cell lethality
CA2530125A1 (en) Use of double-stranded ribonucleic acid for inducing cell lysis
AU2007298990B8 (en) Dbait and uses thereof

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ DUTREIX, MARIE AND SUN, JIAN-SHENG

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 26 NOV 2012 .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 26 NOV 2012

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired